Cost-effectiveness analysis of quadrivalent versus trivalent influenza vaccine in Taiwan: A lifetime multi-cohort model

about

A review of the value of quadrivalent influenza vaccines and their potential contribution to influenza control.

P2860

Q39322780-57DE2FE0-5B9E-4D5A-A26D-1FC86AD3BC21

P2860

Cost-effectiveness analysis of quadrivalent versus trivalent influenza vaccine in Taiwan: A lifetime multi-cohort model

Item

http://www.wikidata.org/entity/Q40582993

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Cost-effectiveness analysis of ...... A lifetime multi-cohort model

@en

type

Item

label

Cost-effectiveness analysis of ...... A lifetime multi-cohort model

@en

prefLabel

Cost-effectiveness analysis of ...... A lifetime multi-cohort model

@en

P1476

Cost-effectiveness analysis of ...... A lifetime multi-cohort model

@en

P2093

Jian-Jhih Su

http://www.w3.org/2001/XMLSchema#string

P2860

Management of Influenza in Adults Older than 65 Years of Age: Cost-Effectiveness of Rapid Testing and Antiviral Therapy

Vaccines for preventing influenza in healthy adults

Vaccines for preventing influenza in the elderly

Vaccines for preventing influenza in healthy children

Nationwide surveillance of influenza during the pandemic (2009-10) and post-pandemic (2010-11) periods in Taiwan.

Using and interpreting cost-effectiveness acceptability curves: an example using data from a trial of management strategies for atrial fibrillation.

The potential cost-effectiveness of quadrivalent versus trivalent influenza vaccine in elderly people and clinical risk groups in the UK: a lifetime multi-cohort model.

Does NICE have a cost-effectiveness threshold and what other factors influence its decisions? A binary choice analysis.

Cost-effectiveness analysis of quadrivalent influenza vaccine versus trivalent influenza vaccine for elderly in Hong Kong.

Surveillance and vaccine effectiveness of an influenza epidemic predominated by vaccine-mismatched influenza B/Yamagata-lineage viruses in Taiwan, 2011-12 season

P304

81-89

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/21645515.2016.1225636

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Ming-chin Yang

Elise Chia-Hui Tan

P577

2016-09-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27624648

http://www.w3.org/2001/XMLSchema#string

P932

5287333

http://www.w3.org/2001/XMLSchema#string

Cost-effectiveness analysis of quadrivalent versus trivalent influenza vaccine in Taiwan: A lifetime multi-cohort model

about

P2860

P2860

Cost-effectiveness analysis of quadrivalent versus trivalent influenza vaccine in Taiwan: A lifetime multi-cohort model

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932